Isaí Eduardo Hernández Padilla

Dr. Isaí Eduardo Hernández Padilla

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in Gastroenterology Insights
Verified
Journal Article
Open access
PDF file
CGCarlos Eugenio Gonzalez
Carlos Eugenio Gonzalez
DCDiego Regalado Ceballos
Diego Regalado Ceballos
SJSamantha Berenice Medrano Juarez
Samantha Berenice Medrano Juarez
ARAiram Regalado-Ceballos
Airam Regalado-Ceballos
IPIsaí Eduardo Hernández Padilla
Isaí Eduardo Hernández Padilla
LMLinda Elsa Muñoz‑Espinosa
Linda Elsa Muñoz‑Espinosa
Left ventricular diastolic dysfunction (LVDD) is a hallmark of cirrhotic cardiomyopathy and has been linked to a poorer quality of life and worse outcomes in patients with end-stage liver disease. Its impact on survival after a liver transplant (LT) is not known, especially when using current diagnostic criteria to define LVDD. We conducted a systematic review and meta-analysis of the current published literature on mortality after a LT in patients with LVDD. We searched for articles in PubMed, Scopus, EMBASE, Web of Science, and the COCHRANE Central database. We included cohort studies that compared post-transplant outcomes between cirrhotic patients with and without LVDD. Our primary outcome of interest was all-cause mortality after a LT in relation to the presence of LVDD per the 2016 American Society of Echocardiography criteria. A total of 1029 articles were screened during the selection process. Two studies included in the meta-analysis showed no significant difference in mortality, but there was high heterogeneity. A narrative review of other studies that classified diastolic function (DD) using different criteria was also performed, revealing an association with worse outcomes in these patients. High-quality prospective studies using current criteria are needed to confirm these findings.

1 October 2023 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
JMJosé Luis Cáceres Medina
José Luis Cáceres Medina
AMAlan Gamboa Meza
Alan Gamboa Meza
IPIsaí Eduardo Hernández Padilla
Isaí Eduardo Hernández Padilla

12 September 2025 in Annals of Hepatology
Verified
Journal Article
Open access
PCPaula Cordero-Pérez
Paula Cordero-Pérez
LTLiliana Torres-González
Liliana Torres-González
SRSamuel Rivas-Lopez
Samuel Rivas-Lopez
CTCarolina Treviño-García
Carolina Treviño-García
ARAiram Regalado-Ceballos
Airam Regalado-Ceballos
LMLinda E. Muñoz-Espinosa
Linda E. Muñoz-Espinosa
Chronic liver disease (CLD) is characterized by a progressive decline in liver function, accompanied by inflammation, destruction, and scarring of the hepatic parenchyma. The most common etiologies of CLD globally include hepatitis B (HBV), hepatitis C (HCV), alcohol-related liver disease, autoimmune liver disease, and, more recently, metabolic dysfunction-associated steatotic liver disease (MASLD). The aim of this study was to analyze the main etiologies of CLD observed in a Hepatology Center over a 25-year period. A retrospective and observational study was conducted with 2679 patients with CLD, recruited between January 1995 and December 2019. The patients were classified into three time periods: Group A (1995-2003), Group B (2004-2011), and Group C (2012-2019). A one-way analysis of variance was used to assess differences between the groups. Significant differences were found in HCV, HBV, and MASLD among the analyzed periods (p = 0.0019, p < 0.001, and p < 0.001, respectively). Tukey's post hoc test revealed significant differences in HCV and HBV between group A and groups B and C (p < 0.01 and p < 0.001, respectively). For MASLD, a progressive increase was observed in each period (p < 0.01 for A vs. B; p ≤ 0.001 for A vs. C; p = 0.0042 for B vs. C). Between 1995 and 2007, the predominant CLD in our clinic was caused by HCV. However, since 2008, MASLD has become the most frequent etiology (33%), reaching 45% in 2019 as the leading cause of CLD. By 2012, cirrhosis due to MASLD had the highest incidence among the analyzed etiologies, followed by HCV.